| 摘要 |
Disclosed is a use of a compound, or a pharmaceutically acceptable salt, enantiomer, or diastereomer thereof, in the preparation of a medicament for the treatment or prevention of metabolic syndrome, Syndrome X, obesity, prediabetes, type II diabetes, hypercholesterolemia, hypertension, coronary heart disease; diabetic neuropathy, diabetic retinopathy, erectile dysfunction, kidney disease, and combinations of anyone of more of said disorders in a mammal, wherein said compound has a structure of the formula (I) wherein: R1 is an alkyl group wherein n is an integer from 0 to 5; X is halogen wherein m is 0 or 1; Y is O, S or NH and Z is O or S; and wherein the sum of m plus n is less than or equal to 5. |
